View Clinical Trial (Medical Research Study)

Study to Promote Weight Loss in Primary Care Practices - NCT00749606-13421(Clinical Trial 240986)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Oneida
State:  
NY
Zip Code: 13421
Conditions: Obesity
Purpose: The purpose of this study is to determine if primary care based, telephone-delivered weight loss interventions are effective.
Study summary: Obesity is related to the rising incidence of type 2 diabetes. Cost-effective interventions leading to sustained weight loss are needed to improve the public health and reverse the alarming rise in diabetes, its cardiovascular complications and other obesity-related illnesses. The Diabetes Prevention Program is identified as a model for a successful weight loss intervention. The proposed study is a randomized controlled trial of 2 active telephone-based interventions based on the Diabetes Prevention Model that will be delivered at primary care sites.
Criteria: Inclusion Criteria: - Obese - Metabolic syndrome - Read and write English - Planning to stay in treatment with their PCP for the next 3 years - On stable doses of medications for chronic diseases such as hypothyroidism for 3 years Exclusion Criteria: - Unstable health - Diabetes mellitus - Severe medical comorbidities that might interfere with their ability to participate in intervention such as severe psychiatric disease or significant heart disease.
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: November 11, 2010
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.